Intravaginal Electrical Stimulation in Idiopathic Overactive Bladder
Bladder Training With and Without Intravaginal Electrical Stimulation in Women With Idiopathic Overactive Bladder: A Prospective Randomised Controlled Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
Overactive bladder (OAB) is a symptom complex defined as urgency, with or without urge urinary incontinence (UUI), usually with frequency and nocturia, in the absence of urinary tract infection. Currently, a wide range of therapeutic options exist for the treatment of OAB. These include first-line conservative (physical) therapies which focus on electrical stimulation (ES) and behavioral therapies such as lifestyle modifications, bladder training (BT), pelvic floor muscle training with or without biofeedback, second-line therapies which are pharmacologic, and third-line therapies which either neuromodulate or chemodenervate the bladder. In clinical practice, BT and Intravaginal ES (IVES) are frequently used together in the treatment of women with OAB, but the evidences/results of the combined (BT+IVES) use of these two treatment options are so rare that they can be neglected in the literature. There is only one study including BT+ES treatment arm (one of the four treatment arms) in women with idiopathic OAB in the literature. In a study, BT+ES was not found to be effective both from BT alone and from the untreated control group. While interpreting the results of this study, it should be take into consideration that patients treated received relatively few treatment sessions (nine treatment sessions, once weekly) in this study. In addition, in the light of authors clinical experience, the investigators think that this issue is still open for research. Moreover, there is no recommendation on conservative combinations in the guidelines due to insufficient data. This study is the first prospective randomized controlled trial that compares the efficacy of BT and BT plus IVES in women with idiopathic OAB. In this study, the investigators aimed to evaluate the efficacy of BT with and without IVES on incontinence-related QoL and clinical parameters in women with idiopathic OAB.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 12, 2020
CompletedFirst Posted
Study publicly available on registry
May 15, 2020
CompletedStudy Start
First participant enrolled
June 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedMay 25, 2021
May 1, 2021
6 months
May 12, 2020
May 24, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
incontinence episodes-incontinence related outcomes measures
Patients with a 50% or greater reduction in incontinence episodes were consider positive responders (number of voiding per day)
8 weeks
Secondary Outcomes (3)
frequency of voiding-incontinence related outcomes measures
8 weeks
nocturia frequency- incontinence related outcomes measures
8 weeks
incontinence related quality of life questionnaire
8 weeks
Study Arms (2)
Group 1: Bladder Training - Control group
OTHERSpecific goals are to correct faulty habit patterns of frequent urination, improve control over bladder urgency, prolong voiding intervals, increase bladder capacity, reduce incontinence episodes and restore patient confidence in controlling bladder function
Group 2: Bladder Training+Intra Vaginal Electrical Stimulation
ACTIVE COMPARATORIVES was performed in lithotomy position via Enraf Nonius Myomed 632 device with a vaginal probe. IVES sessions were performed three times in a week, for 8 weeks. Every session lasted 20 minutes. The intervention comprised a 24-session treatment program of ES. The stimulation parameters were frequency at 10 Hz, a 5-10s work-rest cycle and 100 ms pulse width. The symmetric biphasic pulse wave could be delivered over a range of 0-100 mA. The intensity was controlled according to patients' discomfort level feedback
Interventions
IVES sessions were performed three times in a week, for 8 weeks. Every session lasted 20 minutes. The intervention comprised a 24 session treatment program of IVES.
Bladder Training
Eligibility Criteria
You may qualify if:
- Women over the age of 18 with clinical diagnosis of idiopathic OAB
- Urodynamically diagnosed detrusor overactivity
- The strength of pelvic floor muscle 3/5 and more
- Able to give written, informed consent
- Able to understand the procedures, advantages and possible side effects
- Willing and able to complete the voiding diary and QoL questionnaire
You may not qualify if:
- History of conservative therapy (BT, ES) for OAB within 3 months
- Previously treated with antimuscarinics (within 4 weeks)
- Pregnancy or intention to become pregnant during the study
- Current vulvovaginitis or urinary tract infections or malignancy
- History of urogynecological surgery within 3 months
- Anatomic structural disorders of genital region that could not allow to apply the vaginal probe
- Having stage 2 or more according to the pelvic organ prolapse quantification
- Cardiac pacemaker or implanted defibrillator
- Neurogenic bladder, signs of neurologic abnormalities at objective examination; history of the peripheral or central neurologic pathology
- Ultrasonographic evidence of residual urine volume more than 100 ml
- Allergy to condom or lubricant gel that is used with perineometer/vaginal probe
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hakan Alkan
Denizli, None Selected, 20100, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
May 12, 2020
First Posted
May 15, 2020
Study Start
June 1, 2020
Primary Completion
December 1, 2020
Study Completion
December 31, 2020
Last Updated
May 25, 2021
Record last verified: 2021-05